Back to KNSA overview

KNSA Kiniksa Pharmaceuticals PE ratio, current and historical analysis

The price-to-earnings ratio for Kiniksa Pharmaceuticals stock stands at 156.42 as of Jun 14, 2024. This is calculated based on the current EPS of $0.12 and the stock price of $18.77 per share.

KNSA PE ratio history

How has KNSA's PE ratio performed in the past

Over the last two years, the average PE ratio of Kiniksa Pharmaceuticals has been 45.35. The current 156.42 PE ratio is comparable to the historical average. In the past two years, KNSA's PE ratio was at its highest in the Mar 2024 quarter at 164.42, with a price of $19.73 and an EPS of $0.12. The Mar 2023 quarter recorded the bottom point at 3.82, with a price of $10.76 and an EPS of $2.82.

Average
45.35
Median
5.95
Minimum
3.82
Maximum
164.42

Kiniksa Pharmaceuticals PE ratio by year

Maximum annual increase: 1,446.74% in 2023

Year PE ratio Change
2023 87.7 1,446.74%
2022 5.67 N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A

KNSA average PE ratio chart

What is the average PE ratio of KNSA for the past years

Currently, KNSA's PE ratio is greater than its 3 and 5-year historical averages.

3-year avg
45.35
5-year avg
45.35
10-year avg
N/A
15-year avg
N/A

KNSA PE vs peers

What is KNSA's PE ratio compared to its peers
Stock name PE ratio Market cap
KNSA Kiniksa Pharmaceuticals Ltd 156.42 $1.33B
OCUL Ocular Therapeutix Inc N/A $890.61M
OCX OncoCyte Corp N/A $36.89M
OGEN Oragenics Inc N/A $7.35M

Frequently asked questions

What is Kiniksa Pharmaceuticals's PE ratio?

The price to earnings ratio for KNSA stock as of Jun 14, 2024, stands at 156.42.

What is the 3-year average PE ratio for Kiniksa Pharmaceuticals (KNSA)?

Over the last 3 years, the average price to earnings ratio for KNSA stock is 45.35.

What is the 5-year average PE ratio for Kiniksa Pharmaceuticals (KNSA)?

Over the last 5 years, the average price to earnings ratio for KNSA stock is 45.35.

What is the highest PE ratio for KNSA?

Over the last two years, the quarterly PE ratio reached a historic high of 164.42 in the Mar 2024 quarter.

How does the current PE ratio for KNSA compare to its historical average?

The current price to earnings ratio of KNSA is 245% higher than the 2-year historical average.

Why is Kiniksa Pharmaceuticals's PE ratio so high?

KNSA's PE ratio of 156.42 is considered high because the company's stock price is trading at a higher multiple of earnings.

How is KNSA's PE ratio calculated (Kiniksa Pharmaceuticals PE ratio formula)?

To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Jun 14, 2024), Kiniksa Pharmaceuticals's stock price is $18.77. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $0.12. Therefore, Kiniksa Pharmaceuticals's P/E ratio for today is 156.42. PE RATIO(156.42) = STOCK PRICE($18.77) / TTM EPS($0.12)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.